Clinical Trials Directory

Trials / Completed

CompletedNCT01630356

Controlled Trial to Reduce Secondhand Smoke Exposure at Homes in Armenia

Monitoring Secondhand Smoke Exposure in Buildings in Armenia: Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Not accepted

Summary

This study was designed to test the hypothesis whether a novel intervention that uses motivational interviewing along with immediate feedback and follow-up counseling calls is effective in educating the household members about the health hazards of smoking and secondhand smoke exposure and reducing children exposure to secondhand smoke at households in Armenia. The study was a randomized control trial with two arms: intervention and control groups. The sample population for the study included households with a non-smoking mother and at least one child 2 to 6 years of age residing with at least one daily smoker. The study team recruited the households through pediatrician's offices in polyclinics (primary healthcare facilities) utilizing multistage random sampling. Trained interviewers made two baseline (one week apart) and two 4-month follow-up household visits to conduct measurements, interviews and intervention. Measurements included surveys, air nicotine monitoring in homes and hair samples from children to assess changes in nicotine concentration over time. SHS concentration was estimated by sampling vapor-phase nicotine using a filter badge treated with sodium bisulfate. Airborne nicotine monitors were used in all homes to measure SHS concentration at baseline and 4 month follow-up. At least one monitor was used in each home, preferably in the main room in which the family congregates. Personal exposure to SHS in 2-6 years old children was assessed using biological samples of hair. A small sample of hair (approximately 30 - 50 strands, 2-3 cm) was cut near the hair root from the back of the scalp where there is the most uniform growth pattern between individuals which minimizes the variability of the results. The intervention included an in-person counseling session with distribution of a tailored educational brochure and demonstration/feedback measurement of indoor PM2.5 (at second baseline visit); it also included one and two months follow-up counseling calls. The control group received only a brief educational leaflet on the hazards of second-hand smoke exposure.

Conditions

Interventions

TypeNameDescription
BEHAVIORALin-person counselingThe interventionist provided in person counseling on eliminating child exposure to tobacco smoke to at least one daily smoker and a non-smoker mother in the household. The counseling session emphasized the following issues: a) importance of healthy environment at home, b) health dangers of smoking and exposure to secondhand smoke, c) why and how to quit smoking, and d) how to keep home air smoke-free.
DEVICEDemonstration of PM2.5 PollutionThe study team measured the particulate matter (PM2.5) in the air using the TSI AM 510 Aerosol SidePak to compare the quality of indoor air with outdoor air and demonstrate the effect of smoking on indoor air quality in the intervention households. After completing the Side Pack PM2.5 measurement, the interventionist immediately downloaded the data to a laptop to visualize the results through graphical presentation of the PM2.5 fluctuations to family members.
BEHAVIORALFollow-up Counseling CallsInterventionists made two follow-up counseling calls to the primary contact in the intervention households, usually a non-smoking mother at one and two months after the in-person counseling session. These calls aimed at a) assessing the progress in meeting the goals set earlier, b) counseling on barriers to the change, and c) encouraging study participants to maintain the success or to set new goals. These calls also provided opportunity for the participants to ask questions or clarify issues
BEHAVIORALPrinted materialThe intervention group families received the tailored and culturally adjusted educational brochure developed by the study team. The control group received a brief educational leaflet on the hazards of SHS developed by the US Environmental Protection Agency.

Timeline

Start date
2010-04-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2012-06-28
Last updated
2012-06-28

Locations

1 site across 1 country: Armenia

Source: ClinicalTrials.gov record NCT01630356. Inclusion in this directory is not an endorsement.